NorthWest Biotherapeutics Inc (NWBO)

[Pyrrhonian]

Not sure what you're implying by the relationship between UCLA and NWBO. The exclusive manufacturing rights to DCVax as well as all patents are in the possession and at the sole discretion of NWBO. If anyone is under constraint it is UCLA. They can no longer mention in any study "partially matured DCs loaded with whole tumor lysate," but have to say "DCVax" in all of their testing and trials. They handed over the rights to this vacc to NWBO in return for many obvious privileges. Liau is the PI for the Ph III trial and UCLA the primary institution. Going forward UCLA will be the hub of corporate funded (NWBO) scientific exploration using DCVax. I'm sure there are many arrangements set up for UCLA to manage and have a hand in all of the various trials that will be enacted once DCVax-L is approved. In other words, a massive influx of grant money, as well as full recognition for developing the groundbreaking vaccine. That's the extent of it in public records, and that's plenty for them. So if you're suggesting some cut of the profits going to UCLA, thats just not true, as it would require disclosure (as we've seen in some of MDA's deals).